Implant boosts visual acuity in patients with DME

07/17/2014 | Healio (free registration)

Allergan's Ozurdex steroid-eluting implant fared better than a control group in improving best corrected visual acuity in pseudophakic patients with diabetic macular edema at three years, data from the Macular Edema Assessment of Implantable Dexamethasone in Diabetes indicated. However, more phakic DME patients in the Ozurdex arm developed cataract or lens opacity than those in the non-treatment cohort.

View Full Article in:

Healio (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA